Mirae Asset Global Investments
ZBIO

Mirae Asset Global Investments’s Zenas BioPharma ZBIO Stock Holding History

Mirae Asset Global Investments’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.7K Buy
2,824
+24
+0.9% +$477 ﹤0.01% 1307
2026
Q1 		$54.7K Buy
2,800
+192
+7% +$4.31K ﹤0.01% 1277
2025
Q4 		$94.7K Buy
+2,608
New +$85.8K ﹤0.01% 1269

Other funds holding ZBIO

IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Mirae Asset Global Investments's ZBIO Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Zenas BioPharma (ZBIO) stake by 0.86% in Q2 2026, buying an estimated $477 and bringing the position to 2,824 shares worth $71.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1307.

Mirae Asset Global Investments first reported a position in ZBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $94.7K in Q4 2025. 17 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Mirae Asset Global Investments held 2,824 shares of Zenas BioPharma worth $71.7K as of Q2 2026.
  • Mirae Asset Global Investments bought 24 Zenas BioPharma shares in Q2 2026, an estimated $477.
  • Zenas BioPharma made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1307 holding.
  • Mirae Asset Global Investments first reported a position in Zenas BioPharma in Q4 2025 and has held it in 3 quarters since.
  • Mirae Asset Global Investments's Zenas BioPharma position peaked at $94.7K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.